Ferric Pyrophosphate Citrate Patent Expiration

Ferric Pyrophosphate Citrate is Used for treating patients with iron deficiency and in need of iron replacement therapy. It was first introduced by Rockwell Medical Inc in its drug Triferic on Jan 23, 2015. Another drug containing Ferric Pyrophosphate Citrate is Triferic Avnu.


Ferric Pyrophosphate Citrate Patents

Given below is the list of patents protecting Ferric Pyrophosphate Citrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Triferic US6689275 Method and pharmaceutical composition for replacing iron losses in dialysis patients Dec 31, 2016

(Expired)

Rockwell Medical Inc
Triferic US6779468 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients Dec 31, 2016

(Expired)

Rockwell Medical Inc
Triferic US7816404 Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions Apr 17, 2029 Rockwell Medical Inc
Triferic US7857977 Packaging of ferric pyrophosphate for dialysis Sep 08, 2027 Rockwell Medical Inc
Triferic Avnu US7816404 Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions Apr 17, 2029 Rockwell Medical Inc


Coming Soon

Patent Strength Analyzer

Let us know if you're excited!

🤩🥱

Thank you for your response 🥳